Pages Menu
Categories Menu

Resource Links


ACTG Website

ACTG Drug Interactions Database

Centers for Disease Control (list of AIDS Defining Conditions)

DAIDS Adverse Event reporting

DAIDS Clinical Site Monitoring (CSM) Training Announcement Training Announcement

DAIDS Frequently Asked Questions Regarding DAERS


DAIDS PAB PEP Template Sample Completed DAIDS PAB PEP Template

DAIDS Regulatory and Pharmacovigilence

DAIDS Regulatory Support Center

DAIDS Required Site SOP Samples Sample Templates

FSTRF Portal


NHLBI AIDS Funding Opportunities

PPD Monitor MACE Training

We’re currently seeking study participants to take part in REPRIEVE. Please contact us to learn more.

Latest Tweets

reprievetrial @reprievetrial
REPRIEVE Trial  @reprievetrialJust because #WorldAIDSDay is coming to an end, doesn’t mean the work does. The @reprievetrial will continue to wor… 
REPRIEVE Trial  @reprievetrialREPRIEVE's #FollowYOURHeart campaign for women was established to educate women about HIV-associated heart disease,… 
REPRIEVE Trial  @reprievetrial“Today’s treatments are lifesaving, yet #PLWH still suffer from higher rates of chronic disease than their uninfect… 
REPRIEVE Trial  @reprievetrial#WorldAIDSDay fact: #DYK people with HIV are 50-100% more likely to develop heart disease? The @reprievetrial offer… 
REPRIEVE Trial  @reprievetrial#WorldAIDSDay fact: Women account for nearly half of the HIV positive population. Women’s research participation is… 
REPRIEVE Trial  @reprievetrial#TBT to when @BarbraStreisand visited the NIH to discuss #women in clinical research. Read this op-ed written by…